Lyell Immunopharma, Inc.

NASDAQ:LYEL

0.6063 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -342.994-234.632-183.118-250.219-204.472-129.377
Depreciation & Amortization 19.63120.2518.0213.6244.2941.256
Deferred Income Tax 002.31739.506-5.612-1.518
Stock Based Compensation 33.14447.08481.92462.20133.26115.732
Change In Working Capital -3.123.421-82.0154.015-0.336110.808
Accounts Receivables 000000
Inventory 000000
Accounts Payables -3.2341.4640.6670.091-0.2781.709
Other Working Capital 0.1141.957-82.6823.924-0.058109.099
Other Non Cash Items 130.9450.183-6.6834.62411.99142.573
Operating Cash Flow -162.394-163.694-169.555-126.249-160.87439.474
Investing Activities:
Investments In Property Plant And Equipment -0.464-2.686-24.276-65.504-51.481-16.047
Acquisitions Net 0-186.734-12.736673.46500
Purchases Of Investments -394.707-476.88-406.316-673.465-43.448-34
Sales Maturities Of Investments 548.941663.614419.052617.396686.322238.456
Other Investing Activites -31.346186.73412.736-673.465-864.909-610.842
Investing Cash Flow 122.424184.048-11.54-121.573-273.516-422.433
Financing Activities:
Debt Repayment 000000
Common Stock Issued 02.29.577391.80200
Common Stock Repurchased 36.011-0.457-0.4610-16.05-0.185
Dividends Paid 000000
Other Financing Activities 1.3261.74310.6359.442488.596351.341
Financing Cash Flow 1.3261.74310.635401.244476.79351.156
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -38.64422.097-170.46153.42242.4-31.803
Cash At End Of Period 107.287145.931123.834294.294140.87298.472